Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04593082

Obesity and Pediatric Multiple Sclerosis

Obesity as a Driver of Inflammation and Brain Volume Loss in Pediatric Multiple Sclerosis.

Status
Recruiting
Phase
Study type
Observational
Enrollment
116 (estimated)
Sponsor
University of Virginia · Academic / Other
Sex
All
Age
10 Years – 20 Years
Healthy volunteers
Accepted

Summary

Obesity is one possible contributor to severity of multiple sclerosis and progression of the disease. We already know that obesity is a risk determinant for acquiring MS, yet the impact of obesity on pediatric MS disease expression and course is unknown. This study will evaluate the relationship between obesity, obesity-derived inflammatory mediators, and imaging metrics of MS severity in children. Understanding how childhood obesity contributes to MS severity/progression may yield fundamental insights into disease pathobiology - which may thereby lead to effective strategies for halting its progression in its earliest stages.

Conditions

Timeline

Start date
2021-06-03
Primary completion
2025-06-01
Completion
2025-06-01
First posted
2020-10-19
Last updated
2024-12-09

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04593082. Inclusion in this directory is not an endorsement.